Genomic characterization of dicer1-associated neoplasms uncovers molecular classes

HIGHLIGHTS

• who: Felix K. F. Kommoss from the This study was approved by the institutional ethics committee (Heidelberg University, /2020) and performed in accordance with the Declaration of HelsinkiTumor samples of AS, CN, ERMS, HGESS, LGESS, MAS, MAS/ERMS, MEPL, MG, NCH, PB, PCA, PINB, PIS DICER1, PPB and SLCT had all undergone histopathological evaluation by specialized pathologists, as well as molecular testing whenever applicable. Samples were collected at McGill University-affiliated hospitals in Montreal, Quebec, Canada and the Institute of Pathology, University Hospital Heidelberg, mainly from collaborating institutions in accordance with ethics review board regulations. Eligible participants . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.